Back
Speaker illustration

Doctor Jan Johansson

Resverlogix Inc., San Francisco (United States of America)

Member of:

European Society of Cardiology

Presentations

Vascular and Alzheimer's disease effects by the apoE derived ABCA1 agonist CS6253

Event: ESC Congress 2017

Topic: Basic Science

Session: Cardiovascular care - Biology II

Access
Like
Thumbnail

Lowering the neutrophil to lymphocyte ratio by the BET inhibitor, apabetalone: potential implications for cardiovascular events in high risk patients

Event: ESC Congress 2017

Topic: Inflammation and microcirculation

Session: Coronary artery disease: from bench to bedside

Access
Like
Thumbnail

Atherosclerosis reduction and improved glucose control the ABCA1 agonist CS6253. In vitro and in vivo mechanism of action studies

Event: ESC Congress 2017

Topic: Angiogenesis

Session: Vascular degeneration and restoration

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources